Spironolactone for Non-Female Pattern Hair Loss
Spironolactone can be effective for several types of hair loss beyond female pattern hair loss, including hair loss associated with hormonal conditions, transgender hormone therapy, and hidradenitis suppurativa, though evidence is strongest for female pattern hair loss. 1
Mechanisms and Effectiveness in Different Hair Loss Types
Spironolactone works through multiple anti-androgenic mechanisms:
- Decreases testosterone production
- Competitively inhibits testosterone and dihydrotestosterone binding to androgen receptors
- Inhibits 5α-reductase
- Increases steroid hormone-binding globulin 1
Evidence for Different Hair Loss Types:
Transgender Women/Transfeminine Individuals
- Spironolactone is a primary antiandrogen used in gender-affirming hormone therapy
- Helps decrease facial/body hair and may promote scalp hair retention when used with estrogen 2
- Typically dosed at 50-200 mg daily to bring testosterone levels to <50 ng/dL
Hidradenitis Suppurativa-Related Hair Loss
- Treatment with spironolactone 100-150 mg daily resulted in improvement in 85% of patients
- Complete remission was achieved in 55% of patients with mild to moderate disease
- Less effective in severe disease 2
Androgenetic Alopecia (Both Patterns)
Dosing Guidelines
- Starting dose: 50 mg daily 1
- Titration: Increase to 100 mg daily if needed after 3 months
- Maximum dose: Up to 200 mg daily if tolerated 1
- Treatment response: Typically begins after 3-6 months of consistent use 1
Side Effects and Monitoring
Common side effects include:
- Menstrual irregularities (15-30%)
- Diuresis (29%)
- Breast tenderness (3-5%)
- Dizziness (3-4%)
- Nausea (2-4%) 1
Monitoring recommendations:
- Routine potassium monitoring is not required in young, healthy women 2, 1
- Consider potassium monitoring in older patients and those taking medications affecting potassium levels 2
- Avoid high-potassium foods 1
Important Considerations and Limitations
Gender considerations:
Pregnancy:
- Pregnancy category C
- Should not be used during pregnancy due to potential feminization of male fetuses 1
Combination therapy:
Cancer risk:
Treatment Algorithm for Non-FPHL Hair Loss
Initial assessment:
- Determine if hair loss is hormone-sensitive (worsens with menstrual cycles, associated with other androgenic symptoms)
- Rule out other causes of hair loss (nutritional, autoimmune, etc.)
First-line therapy:
- Start spironolactone 50 mg daily
- Consider adding topical minoxidil 2-5% for enhanced results
Follow-up at 3 months:
- If inadequate response, increase to 100 mg daily
- Add combined oral contraceptive if menstrual irregularities occur
Follow-up at 6 months:
- If still inadequate response, may increase up to 200 mg daily if tolerated
- Consider combination with other therapies based on hair loss type
Maintenance:
- Continue effective dose for long-term management
- Monitor for side effects periodically
While spironolactone is most established for female pattern hair loss, its anti-androgenic properties make it a reasonable option for other types of hormone-influenced hair loss, particularly when conventional treatments have failed.